Stocktoria
METLIFE INC MET
METLIFE INC (MET) earns a Piotroski F-score of 4/9 (mixed financial health). It pays a dividend yielding 2.73% (safety: moderate). FY2025 revenue was $77.1B at a 4.4% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-08-11 | JP Morgan | Overweight (main) |
| 2026-08-11 | Keefe, Bruyette & Woods | Outperform (main) |
| 2026-08-06 | Barclays | Overweight (main) |
| 2026-07-22 | TD Cowen | Buy (main) |
| 2026-07-21 | JP Morgan | Overweight (main) |
| 2026-07-13 | Evercore ISI Group | In-Line (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
How it ranks in Finance, Insurance & Real Estate · percentile among 1129 companies
Percentile vs other Finance, Insurance & Real Estate companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Finance, Insurance & Real Estate companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| MET | METLIFE INC | 4/9 | — | 16.4 | +8.6% |
| PFH | PRUDENTIAL FINANCIAL INC | 6/9 | — | 10.5 | -13.7% |
| ATHS | Athene Holding Ltd. | 4/9 | — | 1.8 | +24.1% |
| RGA | REINSURANCE GROUP OF AMERICA INC | 6/9 | — | 11.9 | +7.2% |
| CRBD | Corebridge Financial, Inc. | 3/9 | — | — | -1.2% |
| LNC | LINCOLN NATIONAL CORP | 2/9 | — | 6 | -1.2% |
| VOYA | Voya Financial, Inc. | 5/9 | — | 12.6 | +1.7% |
All Finance, Insurance & Real Estate companies →
About METLIFE INC
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.
FAQ
Is MET financially healthy?
METLIFE INC's Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).
Does MET pay a dividend, and is it safe?
Yes. METLIFE INC pays a dividend yielding about 2.73% with a 44.7% payout ratio, rated “moderate” for safety.
How profitable is MET?
In FY2025, METLIFE INC had a net margin of 4.4% and a return on equity of 11.8%.
Is MET overvalued or undervalued?
METLIFE INC trades at about 20.5× trailing earnings — above its 10-year norm (10-year range 8.2×–72.4×, median 13.3×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for MET?
The average Wall-Street price target for METLIFE INC is $103.69, about 7.3% above the recent price, from 16 analysts (consensus: buy).
Is MET a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on METLIFE INC: a Piotroski F-score of 4/9, a P/E of about 16.4×, a dividend yield of 2.73%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.